Doctor profile · Federal record
Dr. Gary Reasor, M.D.
Interventional Pain Medicine Physician (CMS: Anesthesiology) · Louisville, KY
- NPI 1457356263
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 38 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
400 Executive Park
Louisville, KY 402074204
(502) 855-7200
fax (502) 855-7201 - Mailing address
-
Po Box 21890
Belfast, ME 049154115
Credentials & registration
- NPI registered
- June 2005 — 21 yrs on file
- Profile last updated
- July 10, 2025
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 208VP0014X — NUCC code
- State license (1)
- Kentucky #26758
- Medicaid
- KY #64267586
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1457356263. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
49,492
Distinct HCPCS
10
Medicare allowed
$668,283
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1170 |
Injection, hydromorphone, up to 4 mg | 34,522 | 59 | $4 | |
J3010 |
Injection, fentanyl citrate, 0.1 mg | 9,310 | 111 | $1 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,655 | 476 | $81 | |
80307 |
Testing for presence of drug, by chemistry analyzers | 1,040 | 480 | $57 | |
62369 |
Electronic analysis reprogramming and refill of spinal canal drug infusion pump | 428 | 98 | $78 | |
J1030 |
Injection, methylprednisolone acetate, 40 mg | 371 | 172 | $8 | |
J2250 |
Injection, midazolam hydrochloride, per 1 mg | 253 | 100 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 210 | 13 | $0 | |
J0475 |
Injection, baclofen, 10 mg | 201 | 18 | $178 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 113 | 75 | $112 |
In context: peer comparison
Among 7 peers in Louisville Interventional Pain Medicine Physician, average services per provider: 496. This provider delivers 100× the peer median.Open Payments
Industry payments received
All-time total
$3,630
Transactions
55
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Medtronic, INC. | 20 | $1,472.88 | |
| Boston Scientific Corporation | 9 | $1,296.63 | |
| Si-Bone, INC. | 7 | $408.40 | |
| Spr Therapeutics, INC | 4 | $145.31 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | 6 | $110.68 | |
| Saluda Medical Americas, INC. | 4 | $106.53 | |
| Abbott Laboratories | 2 | $34.94 | |
| Spinal Simplicity, LLC | 1 | $26.82 | |
| Blue Surgical LLC | 1 | $14.50 | |
| Vertos Medical, INC. | 1 | $13.03 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
11,047
Patients
1,523
Total drug cost
$766,811
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Oxycodone Hcl | Generic | 2,186 | 260 | $115,364 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 2,135 | 273 | $68,170 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 1,977 | 276 | $99,476 |
| Gabapentin | Generic | 1,336 | 241 | $22,113 |
| Morphine Sulfate ER (Morphine Sulfate) | Brand | 484 | 47 | $25,910 |
| Tizanidine Hcl | Generic | 430 | 72 | $7,915 |
| Fentanyl | Generic | 416 | 46 | $61,048 |
| Hydromorphone Hcl | Generic | 358 | 52 | $11,472 |
| Baclofen | Generic | 291 | 49 | $5,251 |
| Cyclobenzaprine Hcl | Generic | 288 | 52 | $2,198 |
Hospital affiliations
Frequently asked questions
What is Dr. Gary Reasor's medical specialty?
Dr. Gary Reasor practices Interventional Pain Medicine Physician in Louisville, KY.
Where does Dr. Gary Reasor practice?
Dr. Gary Reasor practices at 400 Executive Park, Louisville, KY 402074204. Office phone: 5028557200.
What is Dr. Gary Reasor's NPI?
Dr. Gary Reasor's National Provider Identifier (NPI) is 1457356263, issued by NPPES.
Does Dr. Gary Reasor accept Medicare assignment?
Yes. Dr. Gary Reasor accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Gary Reasor commonly perform?
Top Medicare-reported procedures in 2023: Injection, hydromorphone, up to 4 mg (HCPCS J1170); Injection, fentanyl citrate, 0.1 mg (HCPCS J3010); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.